On page 6718 of the 16 June 2011 issue, there are errors in Table 3; 2 categories of risk scores are reversed. In the “Platelet count at cGVHD onset” row in the “Risk score” column, platelet count “≥ 100 × 109/L” should correspond to a score of “0” and platelet count “< 100 × 109/L” should correspond to a score of “1.” Also, in the “Time from transplantation to cGVHD” row in the “Variable” column, “> 5 mo” should be “≥ 5 mo.” In the “Serum bilirubin at cGVHD onset” row in the “Variable” column, “< 2 mg/dL” should be “≤ 2 mg/dL.” In the “KPS at cGVHD onset” row in the “Variable” column, “> 80” should be “≥ 80.” In the “Platelet count at cGVHD onset” in the “Variable” column, “> 100 × 109/L” should be “≥ 100 × 109/L.” The correct table is shown.
Variable . | Risk score . |
---|---|
Recipient age at transplantation | |
< 29 y | 0 |
30-59 y | 1 |
> 60 y | 2 |
Prior acute GVHD | |
None | 0 |
Present | 1 |
Time from transplantation to cGVHD | |
≥ 5 mo | 0 |
< 5 mo | 1 |
Serum bilirubin at cGVHD onset | |
≤ 2 mg/dL | 0 |
> 2 mg/dL | 2 |
KPS at cGVHD onset | |
≥ 80 | 0 |
< 80 | 1 |
Platelet count at cGVHD onset | |
< 100 × 109/L | 1 |
≥ 100 × 109/L | 0 |
Type of donor | |
HLA-identical sibling/well-matched or partially matched URD | 0 |
Other related/mismatched URD | 1 |
Disease status at transplantation | |
Early | 0 |
Intermediate | 1 |
Advanced | 2 |
Sex mismatch (donor/recipient) | |
Male/ male, male/female, female/female | 0 |
Female/male | 1 |
GVHD prophylaxis | |
CSA + MTX + other | 0 |
Tacrolimus + MTX + other or T-cell depletion | 1 |
Variable . | Risk score . |
---|---|
Recipient age at transplantation | |
< 29 y | 0 |
30-59 y | 1 |
> 60 y | 2 |
Prior acute GVHD | |
None | 0 |
Present | 1 |
Time from transplantation to cGVHD | |
≥ 5 mo | 0 |
< 5 mo | 1 |
Serum bilirubin at cGVHD onset | |
≤ 2 mg/dL | 0 |
> 2 mg/dL | 2 |
KPS at cGVHD onset | |
≥ 80 | 0 |
< 80 | 1 |
Platelet count at cGVHD onset | |
< 100 × 109/L | 1 |
≥ 100 × 109/L | 0 |
Type of donor | |
HLA-identical sibling/well-matched or partially matched URD | 0 |
Other related/mismatched URD | 1 |
Disease status at transplantation | |
Early | 0 |
Intermediate | 1 |
Advanced | 2 |
Sex mismatch (donor/recipient) | |
Male/ male, male/female, female/female | 0 |
Female/male | 1 |
GVHD prophylaxis | |
CSA + MTX + other | 0 |
Tacrolimus + MTX + other or T-cell depletion | 1 |
CSA indicates cyclosporine; and MTX, methotrexate.
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal